Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer's disease()

The early diagnostic value of glucose hypometabolism and atrophy as potential neuroimaging biomarkers of mild cognitive impairment (MCI) and Alzheimer's disease (AD) have been extensively explored using [18F]fluorodeoxyglucose positron emission tomography (FDG-PET) and structural magnetic reson...

Descripción completa

Detalles Bibliográficos
Autores principales: Dukart, Juergen, Mueller, Karsten, Villringer, Arno, Kherif, Ferath, Draganski, Bogdan, Frackowiak, Richard, Schroeter, Matthias L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791277/
https://www.ncbi.nlm.nih.gov/pubmed/24179852
http://dx.doi.org/10.1016/j.nicl.2013.07.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791277/
https://www.ncbi.nlm.nih.gov/pubmed/24179852
http://dx.doi.org/10.1016/j.nicl.2013.07.005

Ejemplares similares